Перспективность разработки наружной лекарственной формы с фексофенадином обусловлена возможностью её использования как в симптоматической, так и в комбинированной терапии аллергических проявлений кожи, а также расширением фармацевтического рынка антигистаминных лекарственных средств для наружного применения. В статье изложены исследования по выбору оптимального состава геля с фексофенадином противоаллергического действия, а также обоснован выбор необходимых вспомогательных веществ.Ключевые слова: фексофенадин, гели, мягкая лекарственная форма, антигистаминные препараты.The prospects of topical formulation development with fexofenadine are conditioned by the possibility of its use in symptomatic, as well as in the combined therapy of allergic reactions on a skin, and the expansion of the pharmaceutical market of antihistamine drugs for external application. The article presents a study of a choice of optimal gel composition with fexofenadine with antiallergic action, we have also substantiated the choice of necessary auxiliary substances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.